Lockdown skin cancer diagnosis delays linked to deaths and £6bn costs in Europe

by

Delays in diagnosing melanoma due to COVID-19 lockdown may have contributed to over 100,000 years of life lost across Europe and over £6bn in costs, mainly indirectly due to loss of productivity, finds a new study led by UCL and University Hospital of Basel researchers.

Leave A Comment

Your email address will not be published. Required fields are marked *